Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Editor in Chief
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
7
result was found. Results that relate to
Hepatocellular Carcinoma
Analysis of the expression of TMEM88 in hepatocytes and its relationship with prognosis based on TCGA and other databases
Published on
Journal of Mathematical Medicine
2023,36(4):267-281.
1637 times
493 times
Andrew Liman
Qian ZHU
Bioinformatic
Transmembrane protein 88
Hepatocellular Carcinoma
Details
Current perspectives on tertiary lymphoid structures and PD-1/PD-L1 signaling pathway in the immunotherapy of hepatocellular carcinoma
Published on
New Medicine
2023,33(5):373-380.
1886 times
602 times
Hao-Dong QIAO
Yi-Fan LIU
Ze LIANG
Huai-Bin GUO
Hepatocellular carcinoma
Immunotherapy
PD-1/PD-L1 signaling pathway
Tertiary lymphoid structures
Details
Cost-utility analysis of tislelizumab versus sorafenib as first-line treatment for advanced unresectable hepatocellular carcinoma
Published on
Frontiers in Pharmaceutical Sciences
2024,27(1):109-116.
921 times
417 times
SU Zhan
CHE Jinhui
PEI Ruifeng
Hepatocellular carcinoma
Tislelizumab
Sorafenib
Partition survival model
Pharmacoeconomic analysis
Details
Real-world study of sintilimab combined with bevacizumab in patients with advanced hepatocellular carcinoma
Published on
Frontiers in Pharmaceutical Sciences
2024,27(3):485-490.
971 times
663 times
SU Zhan
CHE Jinhui
PEI Ruifeng
Advanced hepatocellular carcinoma
Sintilimab
Bevacizumab
Clinical efficacy
Safety
Overall survival
Progression-free survival
Details
Efficacy and safety of tislelizumab combined with sorafenib in the treatment for unresectable hepatocellular carcinoma
Published on
Frontiers in Pharmaceutical Sciences
2024,27(8):1136-1342.
913 times
194 times
JIANG Jinghua
HU Yiting
Tirilizumab
Sorafenib
Unresectable
Hepatocellular carcinoma
Objective response rate
Disease control rate
Progression-free survival
Overall survival
Details
Causal association between systemic inflammatory factors and the risk of hepatocellular carcinoma based on Mendelian randomization
Published on
Journal of Mathematical Medicine
2024,37(8):592-599.
1515 times
276 times
LI Xinyu
NIE Duorui
XIAO Tingfen
CAO Jun
WANG Zhiqi
XU Fei
CHEN Chang
Inflammatory factors
Hepatocellular carcinoma
Mendelian randomization analysis
GWAS
Details
Exploring the medication rules of hepatic precancerous lesions based on data mining
Published on
Frontiers in Pharmaceutical Sciences
2024,28(1):80-89.
797 times
151 times
GOU Siyuan
YANG Xianzhao
WANG Longzhu
TIAN Yujia
RU Shuying
Hepatocellular carcinoma
Precancerous lesions
Traditional Chinese medicine
Data mining
Medication rule
Milkvetch root
Largehead atractylodes rhizome
Radix salviae miltiorrhhizae
Details